This afternoon, Jensyn Acquisition Corp. (JSYN), announced that they have closed their business combination with Peck Electric Co., a leading commercial solar engineering, procurement and construction (EPC) company. The combined company will be renamed named “The Peck Company Holdings, Inc.” (“Peck”), whose common stock is expected to be listed on The Nasdaq Capital Market under the symbol “PECK.”
Additionally, more than 87% of the issued and outstanding shares which voted were in favor of the business combination. However, as seems to be the current trend, no details were given as to how many shares redeemed or how many public shares remain. What we do know, is that since Jensyn had only approximately $6.2 million in trust ahead of the vote, this is sure to be another “low float” company post-vote (actually, it was low float going into the vote).
However, Jensyn’s SPAC unit did have Rights, and by now, you know what that means….get ready for some selling pressure. Nonetheless, this should not be another KERN situation (or PHUN, or ORGO, or HUNT…) all of which did not have Rights in their units.
Instead, PECK should trade more like RBZ and WINR, both of which did have Rights.
However, it should be noted that the Jensyn team never gave up. Their deal IPO’d back on March 2, 2016, over three years ago, and while they had multiple extensions (and redemptions) they actually managed to close a deal. Whether this deal “should” have closed is something else entirely, but their persistence is noted.
The transaction is expected to close on June 20, 2019.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...